Capricor Therapeutics Director Disposes of $3.5M in Shares After Exercising Options
Capricor Therapeutics director Sabar Karimah Es sold a combined 115,000 shares of common stock in two trades totaling about $3.5 million, after exercising options to acquire the same number of shares at $4.86 each. The sales, executed under a 10b5-1 plan adopted in December 2025, took place March 31 and April 1, 2026. The company recently reported …